The objective of this research was to evaluate the use of the intravaginal device (CIDR) and estradiol cypionate in synchronization protocols, on oestrus presentation, pregnancy and birth rate in Creole sheep under high altitude conditions. The study was carried out in a non-reproductive season, in the peruvian highlands, using 57 ewes. Four experimental groups were formed: group T1 (n=14) and T3 (n=14), CIDR progesterone device for 7 days and 12 days, respectively; group T2 (n=15) and T4 (n=14), CIDR progesterone device for 7 days and 12 days plus 1 mg of estradiol cypionate, 24 hours after removal of the device in both groups, respectively. Estrous presentation was observed from CIDR removal to 48 hours using vasectomized rams and IATF was performed with fresh semen 48 hours after device removal. The pregnancy rate was determined by ultrasonography at 46 and 90 days after FTAI and the birth rate was recorded. The chi-square test was used for statistical analysis. There was no difference (P>0.05) between groups, for estrous presentation, but there was difference (P<0.05) for pregnancy rate at 46 days between groups with: T1 (42.9%), T3 (38.5%), T4 (21.4%), with respect to T2 (0%) (The difference in results are shown in Table 2). There was a difference (P<0.05) for the pregnancy rate at 90 days: T1 (35.7%) and T3 (30.8%), with respect to T4 (7.1%) and T2 (0 %). The birth rate showed differences (P<0.05) for T1 (28.6%) and T3 (28.6%), with respect to T2 (0%) and T4 (0%). In conclusion, a high pregnancy rate was obtained with CIDR for 7 and 12 days, compared to the use of CIDR plus estradiol cypionate. However, no births were obtained with progesterone plus estradiol cypionate treatment.
|Translated title of the contribution||USE OF CIDR AND ESTRADIOL CYPIONATE IN SYNCHRONIZATION PROTOCOLS ON ESTRUS PRESENTATION, PREGNANCY AND BIRTH RATE IN CREOLE SHEEP UNDER HIGH ALTITUDE CONDITIONS|
|Number of pages||6|
|State||Published - 2021|
Bibliographical noteFunding Information:
This research was carried out with the support of the Pfizer S.A.
© 2021 Asociacion Peruana de Reprouduccion Animal. All rights reserved.